Table 01: Global Glass Vials Market Historic Value (US$ Bn), By Glass Type 2015(H)-2021(A) Table 02: Global Glass Vials Market Forecast Value (US$ Bn), By Glass Type 2022(E)-2032(F) Table 03: Global ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
PARADIS, La. (WVUE) - Three employees of R.J. Vial Elementary School in St. Charles Parish have been arrested following an investigation into alleged mistreatment of a student, authorities ...
Eli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in its direct-to-consumer program. The program offers self-administered vials for people whose insurance ...
Eli Lilly (NYSE:LLY) announced Tuesday it expanded its weight loss drug offerings, launching new 7.5 mg and 10 mg single-dose vial formats of its popular weight loss therapy Zepbound (tirzepatide ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage ...
The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement . That’s about $50 less than current prices.
The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month and bringing its 5 mg single-dose vials down to $499 per month, it said in a Tuesday press release.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results